Breaking News Instant updates and real-time market news.

ARCH

Arch Coal

$91.77

2.175 (2.43%)

06:33
04/23/19
04/23
06:33
04/23/19
06:33

Arch Coal reports Q1 EPS $3.91, consensus $2.43

Reports Q1 revenue $555.18M, consensus $548.48M.

  • 23

    Apr

  • 02

    May

ARCH Arch Coal
$91.77

2.175 (2.43%)

06/06/18
MKMP
06/06/18
NO CHANGE
Target $106
MKMP
Buy
MKM Partners reiterates Buy ratings on Arch Coal, Peabody, Teck Resources
MKM Partners analyst Daniel Scott reiterated Buy ratings on Arch Coal (ARCH), Peabody Energy (BTU) and Teck Resources (TECK), telling investors in a research note that after a prolonged down cycle in coking coal prices, the strength seen for almost two years suggests that supply/demand fundamentals remain "favorable" for producers. The analyst notes that while the fundamentals for domestic thermal coal are improving slowly, exposure to export coking coal is his preferred story. Scott has a $106 price target on Arch Coal, a $53 price target on Peabody and $35 price target on Teck Resources.
11/30/18
BMOC
11/30/18
INITIATION
Target $95
BMOC
Market Perform
Arch Coal initiated with a Market Perform at BMO Capital
BMO Capital analyst David Gagliano initiated Arch Coal with a Market Perform rating and a price target of $95, noting its position as the 2nd largest coal producer in the U.S. based on volume. The analyst believes that the "new" post-bankruptcy Arch is a "well-capitalized met/thermal coal producer that can flourish in periods of strong prices, and withstand periods of weak prices." Gagliano adds however that the expectations of BMO Commodities team for met coal prices to fall about 30% by the end of 2019 is keeping him on the sidelines.
02/15/19
RILY
02/15/19
NO CHANGE
Target $125
RILY
Buy
Arch Coal price target raised to $125 from $111 at B. Riley FBR
B. Riley FBR analyst Lucas Pipes raised his price target for Arch Coal to $125 citing Leer South mine upside following the company's Q4 results. The analyst reiterates a Buy rating on the shares.
02/26/19
RILY
02/26/19
NO CHANGE
Target $125
RILY
Buy
Arch Coal added to Alpha Generator Pick list at B. Riley FBR
B. Riley FBR analyst Lucas Pipes added Arch Coal (ARCH) to his firm's Alpha Generator Pick list in place of Teck Resources (TECK). Arch is the analyst's favorite name in the met coal space due to its "strong" cash flow generation profile, "accommodating" capital return policy, and "attractive" growth project with Leer South. He has a Buy rating on the shares with a $125 price target.

TODAY'S FREE FLY STORIES

ONCE

Spark Therapeutics

$104.41

-0.41 (-0.39%)

07:43
09/18/19
09/18
07:43
09/18/19
07:43
Hot Stocks
Spark Therapeutics, paralympic skier partner for genetic testing awareness »

Spark Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KLAC

KLA-Tencor

$152.55

1.38 (0.91%)

07:42
09/18/19
09/18
07:42
09/18/19
07:42
Recommendations
KLA-Tencor analyst commentary  »

KLA-Tencor price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTVT

vTv Therapeutics

$1.73

-0.045 (-2.54%)

07:40
09/18/19
09/18
07:40
09/18/19
07:40
Hot Stocks
vTv Therapeutics presents additional data from Phase 2 Simplici-T1 study »

vTv Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Oct

07:40
09/18/19
09/18
07:40
09/18/19
07:40
General news
Treasury Market Outlook: yields extended declines overnight »

Treasury Market Outlook:…

GSK

GlaxoSmithKline

$41.10

0.49 (1.21%)

07:38
09/18/19
09/18
07:38
09/18/19
07:38
Conference/Events
FDA Non-Prescription Drugs Advisory Committee to hold a meeting »

The Committee discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 24

    Sep

  • 27

    Sep

  • 02

    Oct

OPGN

OpGen

$7.02

-0.07 (-0.99%)

07:37
09/18/19
09/18
07:37
09/18/19
07:37
Hot Stocks
OpGen says Curetis collaborator obtains option to license ARESdb »

OpGen reported an update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLK

BlackRock

$438.98

3.12 (0.72%)

, TROW

T. Rowe Price

$117.98

1.1 (0.94%)

07:37
09/18/19
09/18
07:37
09/18/19
07:37
Recommendations
BlackRock, T. Rowe Price analyst commentary  »

BlackRock's…

BLK

BlackRock

$438.98

3.12 (0.72%)

TROW

T. Rowe Price

$117.98

1.1 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Sep

  • 27

    Oct

AXDX

Accelerate Diagnostics

$21.30

1.85 (9.51%)

07:36
09/18/19
09/18
07:36
09/18/19
07:36
Hot Stocks
Accelerate Diagnostics reports 'positive' results in three Pheno system studies »

Accelerate Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ADBE

Adobe

$284.59

1.54 (0.54%)

, WWE

WWE

$75.88

1.73 (2.33%)

07:35
09/18/19
09/18
07:35
09/18/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

ADBE

Adobe

$284.59

1.54 (0.54%)

WWE

WWE

$75.88

1.73 (2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

BIIB

Biogen

$238.65

2.54 (1.08%)

07:34
09/18/19
09/18
07:34
09/18/19
07:34
Hot Stocks
Biogen to present new data from SHINE study on safety and efficacy of SPINRAZA »

Biogen announced updates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

IAC

IAC

$236.73

7.5 (3.27%)

, MTCH

Match Group

$79.70

3 (3.91%)

07:33
09/18/19
09/18
07:33
09/18/19
07:33
Recommendations
IAC, Match Group, Angi Homeservices analyst commentary  »

IAC spinoffs could unlock…

IAC

IAC

$236.73

7.5 (3.27%)

MTCH

Match Group

$79.70

3 (3.91%)

ANGI

Angi Homeservices

$7.60

-0.31 (-3.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

EFX

Equifax

$141.79

1.78 (1.27%)

07:32
09/18/19
09/18
07:32
09/18/19
07:32
Hot Stocks
Equifax partners with Urjanet for utility payment data sharing platform »

Equifax and Urjanet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 13

    Nov

BHVN

Biohaven Pharmaceutical

$47.24

-0.8 (-1.67%)

07:32
09/18/19
09/18
07:32
09/18/19
07:32
Hot Stocks
Biohaven Pharmaceutical's verdiperstat selected for ALS platform trial »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$238.65

2.54 (1.08%)

07:32
09/18/19
09/18
07:32
09/18/19
07:32
Hot Stocks
Biogen to initiate DEVOTE clinical trial evaluating higher dose of SPINRAZA »

Biogen announced updates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

FDX

FedEx

$173.53

-0.14 (-0.08%)

, UPS

UPS

$122.40

-0.245 (-0.20%)

07:30
09/18/19
09/18
07:30
09/18/19
07:30
Recommendations
FedEx, UPS analyst commentary  »

Hard to see rebound for…

FDX

FedEx

$173.53

-0.14 (-0.08%)

UPS

UPS

$122.40

-0.245 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

  • 23

    Sep

  • 30

    Sep

  • 01

    Oct

  • 13

    Nov

  • 17

    Dec

MAS

Masco

$41.28

-1.44 (-3.37%)

07:29
09/18/19
09/18
07:29
09/18/19
07:29
Downgrade
Masco rating change  »

Masco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNDM

TNDM

07:24
09/18/19
09/18
07:24
09/18/19
07:24
Conference/Events
Tandem Diabetes management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

ADBE

Adobe

$284.59

1.54 (0.54%)

07:23
09/18/19
09/18
07:23
09/18/19
07:23
Recommendations
Adobe analyst commentary  »

Adobe weakness a buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

GLW

Corning

$28.25

-1.79 (-5.96%)

07:23
09/18/19
09/18
07:23
09/18/19
07:23
Recommendations
Corning analyst commentary  »

Corning shares remain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNH

Syneos Health

$54.63

-0.77 (-1.39%)

07:23
09/18/19
09/18
07:23
09/18/19
07:23
Conference/Events
Syneos Health management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 27

    Sep

AXSM

Axsome Therapeutics

$28.17

-0.97 (-3.33%)

07:23
09/18/19
09/18
07:23
09/18/19
07:23
Initiation
Axsome Therapeutics initiated  »

William Blair starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$173.53

-0.14 (-0.08%)

07:21
09/18/19
09/18
07:21
09/18/19
07:21
Recommendations
FedEx analyst commentary  »

FedEx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 30

    Sep

  • 01

    Oct

  • 13

    Nov

  • 17

    Dec

SU

Suncor

$32.14

-0.31 (-0.96%)

07:21
09/18/19
09/18
07:21
09/18/19
07:21
Conference/Events
Suncor management to meet with Morgan Stanley »

Refinery Tour with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

NERV

Minerva

$8.09

-0.03 (-0.37%)

07:20
09/18/19
09/18
07:20
09/18/19
07:20
Initiation
Minerva initiated  »

Minerva initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZBH

Zimmer Biomet

$138.86

1.25 (0.91%)

07:20
09/18/19
09/18
07:20
09/18/19
07:20
Upgrade
Zimmer Biomet rating change  »

Zimmer Biomet upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.